Smart app tailors virus drug for vulnerable kids
NCT ID NCT06574789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a web app that customizes the dose of the antiviral drug ganciclovir can clear cytomegalovirus (CMV) faster in 232 children with weakened immune systems. Participants are recruited from seven hospitals in Australia and New Zealand. The goal is to see if personalized dosing works better than the standard approach over six weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS VIRAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Monash Children's Hospital
RECRUITINGMelbourne, Victoria, 3168, Australia
-
Perth Children's Hospital
RECRUITINGPerth, Western Australia, 6009, Australia
-
Queensland Children's Hospital
RECRUITINGBrisbane, Queensland, 4101, Australia
-
Starship Children's Hospital
RECRUITINGAuckland, North Island, 1023, New Zealand
-
Sydney Children's Hospital
RECRUITINGSydney, New South Wales, 2031, Australia
-
The Children's Hospital at Westmead
RECRUITINGSydney, New South Wales, 2145, Australia
-
The Royal Children's Hospital
RECRUITINGMelbourne, Victoria, 3052, Australia